(VIANEWS) – JACQUES BOGART (JBOG.PA), ROULARTA (ROU.BR), SWORD GROUP (SWP.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. JACQUES BOGART (JBOG.PA)
451.87% Payout Ratio
Jacques Bogart S.A. produces and sells fragrances and cosmetics in Paris and internationally. It markets its fragrance products under the JACQUES BOGART, CARVEN, CHEVIGNON, and TED LAPIDUS brand names; cosmetic products under the STENDHAL, METHODE JEANNE PIAUBERT, and APRIL brand names; and fashion products under the TED LAPIDUS FASHION brand name. The company was founded in 1975 and is based in Paris, France.
Earnings Per Share
As for profitability, JACQUES BOGART has a trailing twelve months EPS of €-0.61.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.87%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5%, now sitting on 298.63M for the twelve trailing months.
More news about JACQUES BOGART.
2. ROULARTA (ROU.BR)
153.85% Payout Ratio
Roularta Media Group NV operates as a multimedia company in Belgium, the Netherlands, and Germany. The company operates in two segments, Media Brands and Printing Services. It offers general news, business magazines and sports weeklies, lifestyle magazines, and medical and professional magazines; and local papers, Sunday papers, and online and digital marketing solutions, as well as operates business television. It also provides recruitment solutions; brand studio; real estate, printing, and business information services; events, fairs, and networking services; line extensions and rights; and advertising services. In addition, the company engages in subscriptions and sales of the newsstand. Roularta Media Group NV was founded in 1954 and is headquartered in Roeselare, Belgium. Roularta Media Group NV is a subsidiary of Koinon NV.
Earnings Per Share
As for profitability, ROULARTA has a trailing twelve months EPS of €-0.08.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.35%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.3%, now sitting on 335.13M for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 30, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 8%.
Volume
Today’s last reported volume for ROULARTA is 373 which is 80.32% below its average volume of 1896.
Yearly Top and Bottom Value
ROULARTA’s stock is valued at €12.60 at 06:10 EST, way below its 52-week high of €18.50 and above its 52-week low of €11.60.
More news about ROULARTA.
3. SWORD GROUP (SWP.PA)
99.42% Payout Ratio
Sword Group S.E. provides IT and digital transformation services in Europe, the United States, the Oceania, and Asia. The company provides strategic and operational consulting, solution engineering and application development, project ownership support and project management support, infrastructure management and application maintenance for third parties, and resource outsourcing. Its products include Sword Phusion, which capture and manage information in a single, accessible, and reliable form; Sword Tell, a CAD software for watch manufacturers; Sword Venue, a digital collaborative solution with a toolbox to help plan the events; and Sword Aequos that helps to create a flexible and customisable data viewing and search experience. The company serves energy, EPC, chemical, utilities, and manufacturing sector. Sword Group S.E. was founded in 2000 and is headquartered in Windhof, Luxembourg.
Earnings Per Share
As for profitability, SWORD GROUP has a trailing twelve months EPS of €1.71.
PE Ratio
SWORD GROUP has a trailing twelve months price to earnings ratio of 20.23. Meaning, the purchaser of the share is investing €20.23 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.72%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 2, 2023, the estimated forward annual dividend rate is 1.7 and the estimated forward annual dividend yield is 5.52%.
Volume
Today’s last reported volume for SWORD GROUP is 11029 which is 38.74% above its average volume of 7949.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.7%, now sitting on 286.37M for the twelve trailing months.
Yearly Top and Bottom Value
SWORD GROUP’s stock is valued at €34.60 at 06:10 EST, way under its 52-week high of €48.95 and way higher than its 52-week low of €29.60.
More news about SWORD GROUP.
4. EURO RESSOURCES (EUR.PA)
89.93% Payout Ratio
EURO Ressources S.A., a gold resource royalty company, focuses on precious-metal royalties. The company primarily owns a royalty interest in the Rosebel gold mine production located in Suriname; a royalty interest in the Paul Isnard concessions; and a silver stream interest in the Orezone gold corporation situated in French Guiana. It also holds marketable securities related to mining companies. The company was formerly known as Guyanor Ressources S.A. and changed its name to EURO Ressources S.A. in June 2005. The company was incorporated in 1993 and is based in Paris, France. EURO Ressources S.A. operates as a subsidiary of IAMGOLD France S.A.S.
Earnings Per Share
As for profitability, EURO RESSOURCES has a trailing twelve months EPS of €0.28.
PE Ratio
EURO RESSOURCES has a trailing twelve months price to earnings ratio of 11.96. Meaning, the purchaser of the share is investing €11.96 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 52.83%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 7, 2023, the estimated forward annual dividend rate is 0.25 and the estimated forward annual dividend yield is 7.79%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 40.5%, now sitting on 27.82M for the twelve trailing months.
More news about EURO RESSOURCES.
5. ABC ARBITRAGE (ABCA.PA)
81.63% Payout Ratio
ABC arbitrage SA, together with its subsidiaries, engages in the development of arbitrage strategies for liquid assets worldwide. It develops liquidity, statistical, risk, and derivatives arbitrage strategies; and provides asset and portfolio management services. The company was incorporated in 1995 and is based in Paris, France.
Earnings Per Share
As for profitability, ABC ARBITRAGE has a trailing twelve months EPS of €0.37.
PE Ratio
ABC ARBITRAGE has a trailing twelve months price to earnings ratio of 12.69. Meaning, the purchaser of the share is investing €12.69 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.12%.
Volume
Today’s last reported volume for ABC ARBITRAGE is 25916 which is 1.48% above its average volume of 25538.
More news about ABC ARBITRAGE.
6. UCB (UCB.BR)
78.24% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €1.7.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 38.82. Meaning, the purchaser of the share is investing €38.82 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.7%.
Yearly Top and Bottom Value
UCB’s stock is valued at €66.00 at 06:10 EST, way under its 52-week high of €88.80 and higher than its 52-week low of €65.40.
More news about UCB.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
More news about 1.
